Hemodynamic Effects of Cyclic Guanosine Monophosphate-Dependent Signaling Through β3 Adrenoceptor Stimulation in Patients With Advanced Heart Failure: A Randomized Invasive Clinical Trial
- 1 July 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 15 (7) , e009120
Abstract
Background: β3-AR (β3-adrenergic receptor) stimulation improved systolic function in a sheep model of systolic heart failure (heart failure with reduced ejection fraction [HFrEF]). Exploratory findings in patients with New York Heart Association functional class II HFrEF treated with the β3-AR-agonist mirabegron supported this observation. Here, we measured the hemodynamic response to mirabegron in patients with severe HFrEF. Methods: In this randomized, double-blind, placebo-controlled trial we assigned patients with New York Heart Association functional class III–IV HFrEF, left ventricular ejection fraction P =0.039). Pulmonary vascular resistance decreased significantly more in the mirabegron group compared with the placebo group (−1.6 [CI, −0.4 to −2.8] Wood units; P =0.02). No significant differences were seen during exercise. There were no differences in changes in heart rate, systemic vascular resistance, blood pressure, or renal function between groups. Mirabegron was well-tolerated. Conclusions: Oral treatment with the β3-AR-agonist mirabegron for 1 week increased cardiac index and decreased pulmonary vascular resistance in patients with moderate to severe HFrEF. Mirabegron may be useful in patients with worsening or terminal HF. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: 2016-002367-34.Keywords
This publication has 43 references indexed in Scilit:
- β3Adrenergic Stimulation of the Cardiac Na+-K+Pump by Reversal of an Inhibitory Oxidative ModificationCirculation, 2010
- Activation of cAMP-dependent Signaling Induces Oxidative Modification of the Cardiac Na+-K+ Pump and Inhibits Its ActivityJournal of Biological Chemistry, 2010
- Natriuretic peptides stimulate the cardiac sodium pump via NPR-C-coupled NOS activationAmerican Journal of Physiology-Cell Physiology, 2008
- Alloxan-induced diabetes reduces sarcolemmal Na+-K+ pump function in rabbit ventricular myocytesAmerican Journal of Physiology-Cell Physiology, 2007
- Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failureHeart, 2006
- Rate Dependence of [Na + ] i and Contractility in Nonfailing and Failing Human MyocardiumCirculation, 2002
- Hyperaldosteronemia in Rabbits Inhibits the Cardiac Sarcolemmal Na + -K + PumpCirculation Research, 2000
- Milrinone in congestive heart failure: Acute and chronic hemodynamic and clinical evaluationJACC, 1985
- Effect of xamoterol (ICI 118587), a new beta1 adrenoceptor partial agonist, on resting haemodynamic variables and exercise tolerance in patients with left ventricular dysfunction.Heart, 1985
- Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failureThe American Journal of Cardiology, 1982